What Researchers Did
Researchers reviewed current and proposed treatments for ischemic optic neuropathy, including both arteritic and nonarteritic forms.
What They Found
They found that there is no proven effective treatment for ischemic optic neuropathy. While systemic corticosteroids are used for arteritic forms to prevent further damage, numerous therapies for the more common nonarteritic form (NAION) have been unsuccessful. Neuroprotective strategies and optic nerve regeneration studies are currently under investigation.
What This Means for Canadian Patients
Canadian patients with ischemic optic neuropathy currently face a lack of proven effective treatments for this condition. While some therapies are used to prevent further damage in arteritic forms, those with the more common nonarteritic form have no established successful interventions.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The primary limitation highlighted is the current absence of systematically proven effective treatments for ischemic optic neuropathy.